ordinary report insofar as revenues etc go, but they will build. what got my attention was this line ....
After obtaining promising results from a small pre-clinical study in its vaccine development
program the company has decided to advance up to 4 vaccine candidates into pre-clinical
studies. It is anticipated these studies will be conducted over a 12 – 18 month period and
alongside the diagnostics developments will become a new and important area of product
development.
hep c vaccines ..... hmmmm ... cabe ? studies already done .... good stuff ..
Add to My Watchlist
What is My Watchlist?